SAVE THE DATE! 27th Annual BSMO meeting 2025
Mark your calendar: the 27th Annual BSMO meeting 2025 will take place in Bruges on Friday 31 January and Saturday …
Stay up-to-date on the latest (Belgium) Oncology News!
Mark your calendar: the 27th Annual BSMO meeting 2025 will take place in Bruges on Friday 31 January and Saturday …
Find our latest news here. Archive previous editions: January 2024 December 2023 November 2023 October 2023 September 2023 June 2023 …
Een inkijk in hoofd en hart van sleutelfiguren uit de oncologie. We stellen jullie graag onze nieuwe podcastreeks ‘Over kanker en levenskracht‘ voor. …
Precision intiative “Two ongoing comprehensive genomic profiling studies from BSMO: GeNeo and BALLETT” We are proud to present our ongoing …
Recent is er een ABCIP platform o.l.v. Frederic Amant, dewelke kan geraadpleegd worden door collega’s i.g.v. kanker tijdens zwangerschap. Bij …
Dear BSMO members and colleagues, We have the pleasure to invite you for participation in part II of our nationwide, …
Brussels 23 December 2020 BSMO recommendation on COVID-19 vaccination in patients with cancer On 21 December 2020, the EMA has …
The BSMO in collaboration with sciensano published this nationwide population based anaysis of patients with COVID-19 and solid cancer in …
Surgery of the Primary Tumor in De Novo Metastatic Breast Cancer Patients is Associated with Increased Survival: a Nationwide Population …
HIV According to the current literature, immune checkpoint inhibition (ICI) in HIV patients seems to have the same efficacy and …
Generally patients with underlying autoimmune disease (AID) or autoimmune paraneosplastic syndrome (PNS) have mostly been excluded from phase III trials …
Immune checkpoint inhibitors might be used for organ transplant patients under special very controlled circumstances. Malignancy is a significant adverse …